Compare · TMO vs VHUB
TMO vs VHUB
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and VenHub Global Inc. (VHUB): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while VHUB operates in Technology - the two are in different parts of the market.
- TMO is the larger of the two at $179.14B, about 1863.8x VHUB ($96.1M).
- Over the past year, TMO is up 16.3% and VHUB is down 85.8% - TMO leads by 102.1 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 7 for VHUB).
- TMO has more recent analyst coverage (25 ratings vs 0 for VHUB).
- Company
- Thermo Fisher Scientific Inc
- VenHub Global Inc.
- Price
- $482.27-2.41%
- $1.14-18.57%
- Market cap
- $179.14B
- $96.1M
- 1M return
- +6.57%
- +12.32%
- 1Y return
- +16.34%
- -85.75%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 17
- 7
- Recent ratings
- 25
- 0
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)
Latest VHUB
- VenHub Global Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
- VenHub Global Expands Autonomous Retail Platform into Florida
- VenHub Backs Culver City GoPass Program, Helping Deliver More Than 56,000 Student Transit Trips
- Jay Heller, CEO at K Lab AI, Appointed to VenHub Advisory Board
- VenHub Opens Second, Larger Las Vegas Production Facility
- VenHub Extends Flagship Smart Store Partnership at LAX/Metro Transit Center for Additional Two Years
- VenHub Global Inc. filed SEC Form 8-K: Other Events
- SEC Form SCHEDULE 13G filed by VenHub Global Inc.
- VenHub Highlights Rapid Progress Since Nasdaq Debut Including Expanded Smart Store Deployments, Enhanced Technology Platform and Increased Las Vegas Production Capacity
- VenHub Global Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing